DK0467331T3 - O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler - Google Patents

O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler

Info

Publication number
DK0467331T3
DK0467331T3 DK91111948.5T DK91111948T DK0467331T3 DK 0467331 T3 DK0467331 T3 DK 0467331T3 DK 91111948 T DK91111948 T DK 91111948T DK 0467331 T3 DK0467331 T3 DK 0467331T3
Authority
DK
Denmark
Prior art keywords
azithromycin
methyl derivatives
co2ch2c6h5
derivatives
methyl
Prior art date
Application number
DK91111948.5T
Other languages
English (en)
Inventor
Gabrijela Kobrehel
Slobodan Djokic
Gorjana Lazarevski
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Application granted granted Critical
Publication of DK0467331T3 publication Critical patent/DK0467331T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91111948.5T 1990-07-18 1991-07-17 O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler DK0467331T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU140990 1990-07-18

Publications (1)

Publication Number Publication Date
DK0467331T3 true DK0467331T3 (da) 1996-02-05

Family

ID=25554060

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91111948.5T DK0467331T3 (da) 1990-07-18 1991-07-17 O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler

Country Status (20)

Country Link
US (1) US5250518A (da)
EP (1) EP0467331B1 (da)
JP (1) JP2657132B2 (da)
CN (1) CN1029738C (da)
AT (1) ATE129715T1 (da)
BG (1) BG60593B1 (da)
CA (1) CA2046956C (da)
CZ (1) CZ280640B6 (da)
DE (1) DE69114198T2 (da)
DK (1) DK0467331T3 (da)
ES (1) ES2081397T3 (da)
GR (1) GR3018330T3 (da)
HR (1) HRP920491B1 (da)
HU (4) HU221803B1 (da)
PL (1) PL166379B1 (da)
RO (1) RO109338B1 (da)
RU (1) RU2045533C1 (da)
SI (1) SI9011409A (da)
SK (1) SK279075B6 (da)
UA (1) UA27105A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
NZ503897A (en) * 1997-10-16 2002-10-25 Pliva Pharm & Chem Works 3,6-hemiketals from the class of 9a-azalides
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
RU2122549C1 (ru) * 1997-12-29 1998-11-27 Закрытое акционерное общество "Фосфосорб" Способ хроматографического выделения и очистки белков, пептидов и их комплексов
HRP970714B1 (en) * 1997-12-31 2003-08-31 Pliva Pharm & Chem Works Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
HRP980646B1 (en) * 1998-12-30 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Novel oleandomycin derivatives
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
MXPA02008861A (es) * 2000-03-15 2003-02-10 Hanmi Pharm Ind Co Ltd Metodo para preparar claritromicina de cristales de forma ii.
ATE306491T1 (de) 2000-08-23 2005-10-15 Wockhardt Ltd Verfahren zur herstellung von wasserfreiem azithromycin
RU2202619C2 (ru) * 2001-01-09 2003-04-20 Научно-исследовательский институт химии Нижегородского государственного университета им. Н.И. Лобачевского Способ определения общей токсичности твердой, жидкой и газообразной сред
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
EP1482957A4 (en) 2002-02-15 2006-07-19 Merckle Gmbh ANTIBIOTIC CONJUGATES
EP1483579A4 (en) 2002-02-15 2006-07-12 Merckle Gmbh CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS FOR THE PREPARATION AND USE OF CONJUGATES, FORMULATION AND PHARMACEUTICAL APPLICATIONS OBTAINED FROM SUCH CONJUGATES
NZ535354A (en) 2002-02-15 2008-01-31 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7435805B2 (en) * 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
AU2003264910A1 (en) * 2003-05-30 2005-01-21 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
WO2005021567A1 (en) * 2003-09-02 2005-03-10 Pliva - Istrazivacki Institut D.O.O. O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
RS51479B (sr) * 2005-01-13 2011-04-30 Glaxo Group Limited Makrolidi sa anti-inflamatornim dejstvom
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
WO2010086350A1 (en) 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 9-deoxo- 9a-methyl- 9a- aza- 9a-h0m0erythr0mycin a derivatives for the treatment of neutrophil dominated inflammatory diseases
EA201101139A1 (ru) 2009-01-30 2012-03-30 Глэксо Груп Лимитед Противовоспалительный макролид
CN101830949B (zh) * 2009-03-13 2012-05-23 上海医药工业研究院 一种阿奇霉素衍生物、其中间体及其制备方法和应用
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
CN102952166A (zh) * 2011-08-28 2013-03-06 山东方明药业集团股份有限公司 聚合物支载硼氢阴离子还原剂合成阿奇霉素中间体的方法
WO2013148874A1 (en) * 2012-03-27 2013-10-03 Burnet Michael W Anti-inflammatory macrolides
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
WO2018193117A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
CN111148750A (zh) 2017-04-20 2020-05-12 来兴泰德基金会 作为抗癌剂的包含鏻离子的阿奇霉素衍生物
EP3612187B1 (en) 2017-04-21 2022-04-13 Lunella Biotech, Inc. Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
US11229657B2 (en) 2017-04-21 2022-01-25 Lunella Biotech, Inc. Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy
CA3063450A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
CU20190092A7 (es) 2017-05-19 2020-10-20 Lunella Biotech Inc Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas
MX2019014806A (es) 2017-06-26 2020-02-10 Lunella Biotech Inc Mitocetoscinas: agentes terapeuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en celulas cancerosas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
JPS63107994A (ja) * 1986-05-02 1988-05-12 Taisho Pharmaceut Co Ltd エリスロマイシン誘導体
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
PL291130A1 (en) 1992-11-16
DE69114198D1 (de) 1995-12-07
EP0467331B1 (en) 1995-11-02
DE69114198T2 (de) 1996-06-27
CN1029738C (zh) 1995-09-13
HU221803B1 (hu) 2003-01-28
ATE129715T1 (de) 1995-11-15
UA27105A1 (uk) 2000-02-28
HU9802439D0 (en) 1998-12-28
JP2657132B2 (ja) 1997-09-24
RU2045533C1 (ru) 1995-10-10
BG94837A (bg) 1993-12-24
BG60593B1 (bg) 1995-09-29
HRP920491A2 (en) 1994-08-31
HRP920491B1 (en) 1998-10-31
CZ280640B6 (cs) 1996-03-13
CN1059728A (zh) 1992-03-25
HU912408D0 (en) 1991-12-30
JPH05132497A (ja) 1993-05-28
HUT59935A (en) 1992-07-28
PL166379B1 (en) 1995-05-31
CA2046956C (en) 1999-01-05
SI9011409A (en) 1995-10-31
ES2081397T3 (es) 1996-03-01
RO109338B1 (ro) 1995-01-30
CA2046956A1 (en) 1992-01-19
HUT62307A (en) 1993-04-28
HU211659A9 (en) 1995-12-28
EP0467331A1 (en) 1992-01-22
CS219591A3 (en) 1992-03-18
GR3018330T3 (en) 1996-03-31
HU9202619D0 (en) 1992-12-28
HU215158B (hu) 1998-12-28
SK279075B6 (sk) 1998-06-03
US5250518A (en) 1993-10-05

Similar Documents

Publication Publication Date Title
DK0467331T3 (da) O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler
DK0732338T3 (da) 2,2-difluor-3-carbamoylribosesulfonatforbindelser og fremgangsmåde til fremstilling af beta-nucleosider
DK1040107T3 (da) 6-O-alkyl-derivater af erythronolid B
DK0879236T3 (da) Derivater af camptothecin til anvendelse ved behandling af cancer
ES2110421T3 (es) O-bencil-oximeteres y los agentes protectores de las plantas que contienen estos compuestos.
MX9600943A (es) Compuestos de piridonsulfonilurea, procedimientos para su produccion y herbicidas que los contienen.
NO953305L (no) Antranilsyrederivat
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
DK0464465T3 (da) Substituerede aminoalkylbiphenylderivater, antimykotiske præparater indeholdende disse derivater og mellemprodukter til fremstilling deraf
FI864017A0 (fi) 3-vinyl och 3-etynyl- -karbolinderivat, deras framstaellning och deras anvaendning som laekemedel.
DK0632805T3 (da) Melaminderivater til anvendelse i behandlingen af cancer
DK0852580T3 (da) Fremgangsmåde til fremstilling af dihydroxypyrimidin-derivater
DE68920717D1 (de) Reaktivfarbstoffe.
TR199802163T2 (xx) 4'-Triflorometilbifenil-2-karboksilik asit
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
DK0975601T3 (da) Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor
CZ281393B6 (cs) Způsob výroby 6-(substituovaných amino)-propionyl derivátů forskolinu
TR199902699T2 (xx) Yeni disazo boyarmaddeler.
TW358114B (en) Diasazo dyestuffs for dyeing cellulosic materials
DK0971907T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
PT98389A (pt) Processo de preparacao de derivados de estreptogramina
IT1231765B (it) Malte aeree a presa autogena.
GR3002592T3 (en) Polyfunctional ethylenic monomers
DK0533131T3 (da) Fremgangsmåde til selektiv mono-ortho-hydroxy-alkylering af 4-substituerede pyridin-derivater
DK0678515T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 5-oxaspiro[2.4]heptan-on